270 related articles for article (PubMed ID: 26097546)
1. Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.
Mao JW; Tang HY; Zhao T; Tan XY; Bi J; Wang BY; Wang YD
Int J Clin Exp Pathol; 2015; 8(4):3648-58. PubMed ID: 26097546
[TBL] [Abstract][Full Text] [Related]
2. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
Cheng C; Tan J; Qian W; Zhang L; Hou X
Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
[TBL] [Abstract][Full Text] [Related]
3. High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis.
Cheng L; Jin H; Qiang Y; Wu S; Yan C; Han M; Xiao T; Yan N; An H; Zhou X; Shao Q; Xia S
Int Immunopharmacol; 2016 Nov; 40():1-10. PubMed ID: 27567245
[TBL] [Abstract][Full Text] [Related]
4. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
6. Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis.
Su L; Wang JH; Cong X; Wang LH; Liu F; Xie XW; Zhang HH; Wang JH; Fei R; Liu YL
Chin Med J (Engl); 2012 Jan; 125(2):306-11. PubMed ID: 22340564
[TBL] [Abstract][Full Text] [Related]
7. [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model].
Zhang Y; Li J; Chi Y; Li M; Pan X; Zhang Q; He X; Liu Y
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):434-8. PubMed ID: 26080824
[TBL] [Abstract][Full Text] [Related]
8. CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis.
Vonghia L; Ruyssers N; Schrijvers D; Pelckmans P; Michielsen P; De Clerck L; Ramon A; Jirillo E; Ebo D; De Winter B; Bridts C; Francque S
Mediators Inflamm; 2015; 2015():239623. PubMed ID: 26229237
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function.
Wang YC; Jin QM; Kong WZ; Chen J
Int J Clin Exp Pathol; 2015; 8(5):5203-9. PubMed ID: 26191218
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
Mohamed RH; Tarek M; Hamam GG; Ezzat SF
Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751
[TBL] [Abstract][Full Text] [Related]
12. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.
Jiang W; Wu N; Wang X; Chi Y; Zhang Y; Qiu X; Hu Y; Li J; Liu Y
Sci Rep; 2015 Feb; 5():8096. PubMed ID: 25644696
[TBL] [Abstract][Full Text] [Related]
14. [Study on the correlation between small intestinal dendritic cells and non-alcoholic fatty liver disease in mice].
Fang JH; Yu W; Zhou G; Shi JP; Yang WJ; Shen XY; Li GX
Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):698-703. PubMed ID: 31594095
[No Abstract] [Full Text] [Related]
15. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
16. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.
Tian Y; Wang H; Yuan F; Li N; Huang Q; He L; Wang L; Liu Z
Biomed Res Int; 2016; 2016():9462571. PubMed ID: 27051672
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
18. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
19. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
[TBL] [Abstract][Full Text] [Related]
20. Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota.
Wang Y; Lv S; Shen T; Ye M; Wang D; Zhou P; Li Y; Zhang W
Ann Palliat Med; 2021 Mar; 10(3):3219-3234. PubMed ID: 33849107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
